Table 1.
Antibiotype | Resistance profilea | Total no. of isolates (%) | PFGE types (subtypes) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OXA | PEN | CIP | ERY | CLI | RIF | GEN | LZD | SXT | TEC | TET | VAN | |||
1 | R | R | R | R | S | S | S | S | S | S | S | S | 67 (63.2) | A (1–9); B (1, 2); D (1) |
2 | R | R | R | S | S | S | S | S | S | S | S | S | 24 (22.7) | A (1–6); B (1, 4); C (1) |
3 | R | R | S | R | S | S | S | S | S | S | S | S | 7 (6.6) | A (1, 2, 5); B (1) |
4 | R | R | R | R | R | S | S | S | S | S | S | S | 3 (2.8) | A (1) |
5 | R | R | S | S | S | S | S | S | S | S | S | S | 2 (1.9) | A (4); B (3) |
6 | R | R | R | S | S | R | S | S | S | S | S | S | 1 (0.9) | A (1) |
7 | R | R | S | S | I | R | R | S | S | S | S | S | 1 (0.9) | B (1) |
8 | R | R | R | R | R | R | S | S | S | S | S | S | 1 (0.9) | B (1) |
a S, susceptible; I, intermediate; R, resistant
Antibiotic abbreviations: OXA, oxacillin; PEN, penicillin; CIP, ciprofloxacin; ERY, erythromycin; CLI, clindamycin; RIF, rifampicin; GEN, gentamicin; LZD, linezolid; SXT, trimethoprim-sulfamethoxazole; TEC, teicoplanin; TET, tetracycline; VAN, vancomycin